Investigating the oncolytic bacteria product SGN1 and its impact on PD-L1 expression, CD8+ T cell infiltration, and synergy with anti-PD-L1 combo in preclinical models of pancreatic adenocarcinoma, hepatocellular cancer, and melanoma.

Authors: Jialuo Mai, Lanhong Su, Yunfen Li, Christie Chiu, Ping Mao, Qiumei Huang, Xinyu Mo, Fanghong Li, Allan Zijian Zhao

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15188

Source: Full article

e15188